Dedifferentiation of a well-differentiated liposarcoma to a highly malignant metastatic osteosarcoma: Amplification of 12q14 at all stages and gain of 1q22-q24 associated with metastases

Cancer Genetics and Cytogenetics

Volumn 125, Issue 2, 2001, Pages 100-111

  Forus, Anne ^a   Larramendy, Marcelo L ^b,c   Meza Zepeda, Leonardo A ^a   Bjerkehagen, Bodil ^a   Godager, Linda H ^a   Dahlberg, Anine B ^a   Saeter, Gunnar ^a   Knuutila, Sakari ^b   Myklebost, Ola ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF HELSINKI   (Finland)

^c FACULTAD DE CIENCIAS NATURALES Y MUSEO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE; IFOSFAMIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASE REPORT; CENTROMERE; CHROMOSOME 12Q; CHROMOSOME 1Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HISTOLOGY; HUMAN; HUMAN TISSUE; LIPOSARCOMA; LUNG METASTASIS; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; NORTHERN BLOTTING; OSTEOSARCOMA; PHENOTYPE; PRIORITY JOURNAL; RETROPERITONEAL TUMOR; SOUTHERN BLOTTING; TUMOR DEDIFFERENTIATION; TUMOR DIFFERENTIATION; TUMOR XENOGRAFT;

ADULT; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CELL DIFFERENTIATION; CENTROMERE; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 12; COMBINED MODALITY THERAPY; FATAL OUTCOME; FEMALE; FOLLOW-UP STUDIES; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIPOSARCOMA; LUNG NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; ONCOGENES; OSTEOSARCOMA; RETROPERITONEAL NEOPLASMS;

EID: 0035032709     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(00)00369-1     Document Type: Article

References (45)

1. rd ed. Gray, SM, editor. St. Louis, MO: Mosby-Year Book Inc., 1995.
2. Fanburg-Smith J.C., Miettinen M. Liposarcoma with meningothelial-like whorls. a study of 17 cases of a distinctive histological pattern associated with dedifferentiated liposarcoma Histopathology. 33:1998;414-424.
3. Weiss S.W., Rao V.K. Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites. A follow- up study of 92 cases with analysis of the incidence of "dedifferentiation" Am J Surg Pathol. 16:1992;1051-1058.
4. Evans H.L. Liposarcoma. a study of 55 cases with reassessment of its classification Am J Surg Pathol. 3:1979;507-523.
5. Evans H.L., Khurana K.K., Kemp B.L., Ayala A.G. Heterologous elements in the dedifferentiated component of dedifferentiated liposarcoma. Am J Surg Pathol. 18:1994;1150-1157.
6. McCormick D., Mentzel T., Beham A., Fletcher C.D. Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol. 18:1994;1213-1223.
7. Henricks W.H., Chu Y.C., Goldblum J.R., Weiss S.W. Dedifferentiated liposarcoma. a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation Am J Surg Pathol. 21:1997;271-281.
8. Nascimento A.G., Kurtin P.J., Guillou L., Fletcher C.D. Dedifferentiated liposarcoma. a report of nine cases with a peculiar neurallike whorling pattern associated with metaplastic bone formation Am J Surg Pathol. 22:1998;945-955.
9. Dei Tos A.P., Doglioni C., Piccinin S., Maestro R., Mentzel T., Barbareschi M., Boiocchi M., Fletcher C.D. Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma. J Pathol. 181:1997;8-13.
10. Pedeutour F., Forus A., Coindre J.M., Berner J.-M., Nicolo G., Michiels J.F., Terrier P., Ranchere-Vince D., Collin F., Myklebost O., Turc-Carel C. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer. 24:1999;30-41.
11. Simms W.W., Ordonez N.G., Johnston D., Ayala A.G., Czerniak B. p53 expression in dedifferentiated chondrosarcoma. Cancer. 76:1995;223-227.
12. Forus A., Flørenes V.A., Maelandsmo G.M., Meltzer P.S., Fodstad Ø, Myklebost O. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas. some amplica do not include MDM2 Cell Growth Differ. 4:1993;1065-1070.
13. Suijkerbuijk R.F., Sinke R.J., Olde Weghuis D.E.M., Roque L., Forus A., Stellink F., Siepman A., van de Kaa C., Soares J., Geurts van Kessel A. Amplification of chromosome subregion 12p11.2-p12.1 including the PTHLH gene in a metastasis of an I(12p)-negative seminoma. relationship to tumor progression? Cancer Genet Cytogenet. 78:1994;145-152.
14. Larramendy M.L., Tarkkanen M., Blomqvist C., Virolainen M., Wiklund T., Asko-Seljavaara S., Elomaa I., Knuutila S. Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol. 151:1997;1153-1161.
15. Forus A., Berner J.-M., Meza-Zepeda L.A., Saeter G., Mischke D., Fodstad Ø, Myklebost O. Molecular characterisation of a novel amplicon at 1q21-q22 frequently observed in human sarcomas. Br J Cancer. 78:1998;495-503.
16. Kerstens H.M.J., Poddighe P.J., Hanselaar A.G.J.M. A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine. J Histochem Cytochem. 43:1995;347-352.
17. Raap A.K., van de Corput M.P.C., Vervenne R.A.W., van Gijlswijk R.P.M., Tanke H.J., Wiegant J. Ultra-sensitive FISH using peroxidase-mediated deposition of biotin-or fluorochrome tyramides. Hum Mol Genet. 4:1995;529-534.
18. Huang L.S., Bock S.C., Feinstein S.I., Breslow J.L. Human apolipoprotein B cDNA clone isolation and demonstration that liver apolipoprotein B mRNA is 22 kilobases in length. Proc Natl Acad Sci USA. 82:1985;6825-6829.
19. Oliner J.D., Kinzler K.W., Meltzer P.S., George D.L., Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature. 358:1992;80-83.
20. Su Y.A., Trent J.M., Guan X.-Y., Meltzer P.S. Direct isolation of genes encoded within a homogenously staining region by chromosome microdissection. Proc Natl Acad Sci USA. 91:1994;9121-9125.
21. Kools P.F.J., Van de Ven W.J.M. Amplification of a rearranged form of the high-mobility group protein gene HMGIC in OSA-cl osteosarcoma cells. Cancer Genet Cytogenet. 91:1996;1-7.
22. Hannon G.J., Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature. 371:1994;257-261.
23. Weiss M.J., Ray K., Henthorn P.S., Lamb B., Kadesch T., Harris H. Structure of the human liver/bone/kidney alkaline phosphatase gene. J Biol Chem. 263:1988;12002-12010.
24. Wion K.L., Kirchgessner T.G., Lusis A.J., Schotz M.C., Lawn R.M. Human lipoprotein lipase complementary DNA sequence. Science. 235:1987;1638-1645.
25. Marenholz I., Volz A., Ziegler A., Davies A., Ragoussis I., Korge B.P., Mischke D. Genetic analysis of the epidermal differentiation complex (EDC) on human chromosome 1q21. chromosomal orientation, new markers and a 6 Mbp YAC contig Genomics. 37:1996;295-302.
26. Khatib Z.A., Matsushime H., Valentine M., Shapiro D.N., Sherr C.J., Look A.T. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res. 53:1993;5535-5541.
27. Myklebost O., Stenwig A.E., Fodstad Ø The analysis of gene expression in liposarcoma, mesenchymal tumours resembling various stages of adipose differentiation. J Cell Biochem Suppl. 18A:1994;163.
28. Momand J., Jung S., Wilczynski S., Niland J. The MDM2 gene amplification database. Nucl Acid Res. 26:1998;3453-3459.
29. Geurts van Kessel A., Simons A., Comtesse P.P., Siepman A., Janssen I., Suijkerbuijk R.F., Forus A., Pruszczynski M., Veth R.P. Ring chromosomes in a malignant mesenchymoma. Cancer Genet Cytogenet. 109:1999;119-122.
30. Nilbert M., Rydholm A., Willen H., Mitelman F., Mandahl N. MDM2 gene amplification correlates with ring chromosomes in soft tissue tumors. Genes Chromosomes Cancer. 9:1994;261-265.
31. Pedeutour F., Suijkerbuijk R.F., Forus A., van Gaal J., van de Klundert W., Coindre J.-M., Nicolo G., Collin F., van Haelst U., Huffermann K., Turc-Carel C. Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma. Genes Chromosomes Cancer. 10:1994;85-94.
32. Nilbert M., Rydholm A., Mitelman F., Meltzer P.S., Mandahl N. Characterization of the 12q13-15 amplicon in soft tissue sarcomas. Cancer Genet Cytogenet. 83:1995;32-36.
33. Pilotti S., Della Torre G., Lavarino C., Sozzi G., Minoletti F., Vergani B., Azzarelli A., Rilke F., Pierotti M.A. Molecular abnormalities in liposarcoma. role of MDM2 and CDK4-containing amplicons at 12q13-22 J Pathol. 185:1998;188-190.
34. Forus A., Flørenes V.A., Maelandsmo G.M., Fodstad Ø, Myklebost O. 12q13-14 amplica in human sarcomas without MDM2 include CDK4, SAS and GADD153/CHOP. Cancer Genet Cytogenet. 77:1994;200.
35. Maelandsmo G.M., Berner J.-M., Flørenes V.A., Forus A., Hovig E., Fodstad Ø, Myklebost O. Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas-relationship to amplification and mRNA levels of CDK4 and CCND1. Br J Cancer. 72:1995;393-398.
36. Berner J.-M., Forus A., El Kahloun A., Meltzer P.S., Fodstad Ø, Myklebost O. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Genes Chromosomes Cancer. 17:1996;254-259.
37. Forus A., Schmitt J.-M., Pedeutour F., Turc-Carel C., Meltzer P.S., Fodstad Ø, Myklebost O. Amplification of 12q13-14 in human sarcoma. is there a common selective gene, or are different mechanisms important in different sets of tumours? Cytogenet Cell Genet. 67:1994;269.
38. Forus A., Olde Weghuis D., Smeets D., Fodstad Ø, Myklebost O., Geurts van Kessel A. Comparative genomic hybridization analysis of human sarcomas. I. Occurence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas Genes Chromosomes Cancer. 14:1995;8-14.
39. Forus A., Olde Weghuis D., Smeets D., Fodstad Ø, Myklebost O., Geurts van Kessel A. Comparative genomic hybridization analysis of human sarcomas. II. Identification of novel amplicons at 6p and 17p in osteosarcomas Genes Chromosomes Cancer. 14:1995;15-21.
40. Szymanska J., Tarkkanen M., Wiklund T., Virolainen M., Blomquist C., Asko-Seljavaara S., Tukiainen E., Elomaa I., Knuutila S. Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization. Genes Chromosomes Cancer. 15:1996;89-94.
41. Szymanska J., Virolainen M., Tarkkanen M., Wiklund T., Asko-Seljavaara S., Tukiainen E., Elomaa I., Blomqvist C., Knuutila S. Overrepresentation of 1q21-q23 and 12q13-q21 in lipoma-like liposarcomas but not in benign lipomas. A comparative genomic hybridization study Cancer Genet Cytogenet. 99:1997;14-18.
42. Tarkkanen M., Elomaa I., Blomqvist C., Kivioja A.H., Kellokumpu-Lehtinen P., Bohling T., Valle J., Knuutila S. DNA sequence copy number increase at 8q. a potential new prognostic marker in high-grade osteosarcoma Int J Cancer. 84:1999;114-121.
43. Gronwald J., Storkel S., Holtgreve-Grez H., Hadaczek P., Brinkschmidt C., Jauch A., Lubinski J., Cremer T. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites. Importance of 1q and 3p copy number changes in metastatic events Cancer Res. 57:1997;481-487.
44. Tarkkanen M., Karhu R., Kallioniemi A., Elomaa I., Kivioja A.H., Nevalainen J., Bohling T., Karaharju E., Hyytinen E., Knuutila S., Kallioniemi O.-P. Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res. 55:1995;1334-1338.
45. Gisselson D., Hoglund M., Mertens F., Mitelman F., Mandahl N. Chromosomal organization of amplified chromosome 12 sequences in mesenchymal tumors detected by fluorescence in situ hybridization. Genes Chromosomes Cancer. 23:1998;203-212.